Deadline: 16-Sep-2026
The MRFF 2026 BioMedTech Incubator Program offers substantial funding to establish incubators that support early-stage medical research and innovation with strong commercial potential in Australia.
The program focuses on improving the health and wellbeing of Australians by increasing the number of small and medium enterprises developing novel biomarkers, diagnostics, therapeutics, assistive devices, and digital technologies, while enabling these innovations to progress through early research and development stages to become de-risked and attractive for private investment and commercialisation.
The grant opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative and is designed to support organisations capable of establishing BioMedTech incubators. These incubators will identify, select, and assist Australian SMEs working on promising early-stage medical research and innovation projects. Applicants are not required to cover the entire biomedtech sector and may instead focus on their specific areas of expertise and strength.
Eligible organisations can receive grants of up to $33 million to establish and operate these incubators, with a total funding pool of up to $132 million allocated over four years from 2026–27 to 2029–30. The funding is distributed progressively across the years, ensuring sustained support for the development and scaling of innovative projects.
Projects funded under this opportunity must be completed within five years from the start date, allowing sufficient time for early-stage innovations to mature and reach a stage where they can attract private investment.
To be eligible, applicants must have an Australian Business Number, be incorporated in Australia, and fall into one of the specified categories, including medical research institutes, universities, corporate Commonwealth entities, or corporations such as businesses and not-for-profit organisations.
This program is specifically intended for organisations that can build and manage effective incubators, partnering with Australian SMEs to guide innovative medical research projects through the critical early phases of development and toward commercial readiness.
For more information, visit Australian Government.
